Midwest Eye Institute Northside

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Macular degeneration4 trials

Phase

• Phase 23 trials

Status

• Terminated3 trials
• Enrolling by invitation1 trial

Lead sponsor

• Gyroscope Therapeutics Limited4 trials

Running trials

• Enrolling by invitation

  ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study

  NCT05481827· Phase 2· Gyroscope Therapeutics Limited· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting

Closed trials

• Terminated

  HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04566445· Phase 2· Gyroscope Therapeutics Limited· Source

• Terminated

  EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04437368· Phase 2· Gyroscope Therapeutics Limited· Source

• Terminated

  GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

  NCT03894020· Gyroscope Therapeutics Limited· Source